By Sabela Ojea Alnylam Pharmaceuticals said that it received a positive review from the U.S. Food and Drug Administration regarding its supplemental new drug.
By Ben Glickman Rocket Pharmaceuticals said it had reached alignment with the Food and Drug Administration on its Phase 2 trial of its treatment for Danon.
By Christian Moess Laursen Shares in Genedrive rose 20% after the company said its test for treating stroke patients is now readying for National Health.